| The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily C Biswas, Y Zhang, R DeCastro, H Guo, T Nakamura, H Kataoka, ... Cancer research 55 (2), 434-439, 1995 | 998 | 1995 |
| Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase H Kataoka, R DeCastro, S Zucker, C Biswas Cancer Research 53 (13), 3154-3158, 1993 | 316 | 1993 |
| Factor XII inhibition reduces thrombus formation in a primate thrombosis model A Matafonov, PY Leung, AE Gailani, SL Grach, C Puy, Q Cheng, M Sun, ... Blood, The Journal of the American Society of Hematology 123 (11), 1739-1746, 2014 | 228 | 2014 |
| Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA M Takeshita, Y Ishida, E Akamatsu, Y Ohmori, M Sudoh, H Uto, ... Journal of biological chemistry 284 (32), 21165-21176, 2009 | 177 | 2009 |
| Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma H Kataoka, R Hamasuna, H Itoh, N Kitamura, M Koono Cancer research 60 (21), 6148-6159, 2000 | 160 | 2000 |
| Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor H Kataoka, S Miyata, S Uchinokura, H Itoh Cancer and Metastasis Reviews 22, 223-236, 2003 | 156 | 2003 |
| Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the … H Kataoka, T Shimomura, T Kawaguchi, R Hamasuna, H Itoh, N Kitamura, ... Journal of Biological Chemistry 275 (51), 40453-40462, 2000 | 154 | 2000 |
| Invited Reviews-Cohort migration of carcinoma cells: Differentiated colorectal carcinoma cells move as coherent cell clusters or sheets K Nabeshime, T Inoue, Y Shimao, H Kataoka, M Koono Histology and histopathology 14 (4), 1183-1198, 1999 | 153 | 1999 |
| Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma Y Haruyama, H Kataoka World journal of gastroenterology 22 (1), 275, 2016 | 140 | 2016 |
| Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues: cellular surface localization of HAI-1 in simple columnar epithelium and its … H Kataoka, T Suganuma, T Shimomura, H Itoh, N Kitamura, K Nabeshima, ... Journal of Histochemistry & Cytochemistry 47 (5), 673-682, 1999 | 132 | 1999 |
| Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer R DeCastro, Y Zhang, H Guo, H Kataoka, MK Gordon, BP Toole, ... Journal of Investigative Dermatology 106 (6), 1260-1265, 1996 | 130 | 1996 |
| Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of α1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in … H Kataoka, H Uchino, T Iwamura, M Seiki, K Nabeshima, M Koono The American journal of pathology 154 (2), 457-468, 1999 | 119 | 1999 |
| Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad D Matsubara, Y Kanai, S Ishikawa, S Ohara, T Yoshimoto, T Sakatani, ... Journal of Thoracic Oncology 7 (12), 1872-1876, 2012 | 117 | 2012 |
| Mechanisms of hepatocyte growth factor activation in cancer tissues M Kawaguchi, H Kataoka Cancers 6 (4), 1890-1904, 2014 | 113 | 2014 |
| Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24 T Fukushima, T Tezuka, T Shimomura, S Nakano, H Kataoka Journal of Biological Chemistry 282 (25), 18634-18644, 2007 | 112 | 2007 |
| Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT T Fukushima, H Takeshima, H Kataoka Anticancer research 29 (11), 4845-4854, 2009 | 108 | 2009 |
| Activation of c‐Met (hepatocyte growth factor receptor) in human gastric cancer tissue T Inoue, H Kataoka, K Goto, K Nagaike, K Igami, D Naka, N Kitamura, ... Cancer science 95 (10), 803-809, 2004 | 104 | 2004 |
| Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta H Tanaka, K Nagaike, N Takeda, H Itoh, K Kohama, T Fukushima, ... Molecular and cellular biology 25 (13), 5687-5698, 2005 | 102 | 2005 |
| Regulation of matrix metalloproteinase‐2 (MMP‐2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP‐2 expression and activation … R Hamasuna, H Kataoka, T Moriyama, H Itoh, M Seiki, M Koono International journal of cancer 82 (2), 274-281, 1999 | 102 | 1999 |
| Amyloid β protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo JY Meng, H Kataoka, H Itoh, M Koono International Journal of Cancer 92 (1), 31-39, 2001 | 97 | 2001 |
